The mechanistic basis of IGF2BP2's role in PCa involves METTL3-mediated m6A modification of Prostate Cancer Associated Transcript 6 (PCAT6), leading to the upregulation of PCAT6 in an IGF2BP2-dependent manner [134]. This evidence concerns the gene IGF2BP2 and posterior cortical atrophy.